Although incident off-label oral cannabinoid use was relatively low among all older Ontarian adults, this drug class was used with greater frequency and more often in potentially concerning ways among older adults with COPD.
Older Adults with COPD Were Prescribed Synthetic Cannabinoids More Oftenโand at Higher DosesโThan Those Without the Disease
Incident synthetic oral cannabinoid use during this period occurred with significantly greater frequency among older adults with COPD (0.6%) versus older adults without COPD (0.3%), and those with COPD used these drugs for significantly longer durations and more frequently at higher doses.
Reducing severe breathlessness with dronabinol in the group of patients with severe and very severe chronic obstructive pulmonary disease (BONG): a randomised, double-blinded, placebo-controlled, crossover study in an outpatient clinic in Denmark
Cannabis-based medicine may alleviate breathlessness. This study will investigate whether dronabinol, a synthetic form of ฮ This single-centre, randomised, d…